Classification of natural products as sources of drugs according to the biopharmaceutics drug disposition classification system(BDDCS)

被引:0
|
作者
LI Ji [1 ]
Caroline A.Larregieu [2 ]
Leslie Z.Benet [2 ]
机构
[1] Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University
[2] Department of Bioengineering & Therapeutic Science, University of California
关键词
Biopharmaceutics Drug Disposition Classification System(BDDCS); Natural products(NPs); Dose number; Solubility and extent of metabolism;
D O I
暂无
中图分类号
R915 [药物生物学];
学科分类号
1007 ;
摘要
Natural products(NPs) are compounds that are derived from natural sources such as plants, animals, and microisms. Therapeutics has benefited from numerous drug classes derived from natural product sources. The Biopharmaceutics Drug position Classification System(BDDCS) was proposed to serve as a basis for predicting the importance of transporters and enzymes in determining drug bioavailability and disposition. It categorizes drugs into one of four biopharmaceutical classes according to their water solubility and extent of metabolism. The present paper reviews 109 drugs from natural product sources: 29% belong to class 1(high solubility, extensive metabolism), 22% to class 2(low solubility, extensive metabolism), 40% to class 3(high solubility, poor metabolism), and 9% to class 4(low solubility, poor metabolism). Herein we evaluated the characteristics of NPs in terms of BDDCS class for all 109 drugs as wells as for subsets of NPs drugs derived from plant sources as antibiotics. In the 109 NPs drugs, we piled 32 drugs from plants, 50%(16) of total in class 1, 22%(7) in class 2 and 28%(9) in class 3, none found in class 4; Meantime, the antibiotics were found 5(16%) in class 2, 22(71%) in class 3, and 4(13%) in class 4; no drug was found in class 1. Based on this classification, we anticipate BDDCS to serve as a useful adjunct in evaluating the potential characteristics of new natural products.
引用
收藏
页码:888 / 897
页数:10
相关论文
共 50 条
  • [41] Applying the Biopharmaceutics Classification System to veterinary pharmaceutical products Part I: Biopharmaceutics and formulation considerations
    Martinez, M
    Augsburger, L
    Johnston, T
    Jones, WW
    ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (06) : 805 - 824
  • [42] Considerations for a Pediatric Biopharmaceutics Classification System (BCS): Application to Five Drugs
    Gandhi, Shivani V.
    Rodriguez, William
    Khan, Mansoor
    Polli, James E.
    AAPS PHARMSCITECH, 2014, 15 (03): : 601 - 611
  • [43] Considerations for a Pediatric Biopharmaceutics Classification System (BCS): Application to Five Drugs
    Shivani V. Gandhi
    William Rodriguez
    Mansoor Khan
    James E. Polli
    AAPS PharmSciTech, 2014, 15 : 601 - 611
  • [44] Simulation-based comparison of Biopharmaceutics Classification System and drug structure
    Chen, Tianyu
    Wu, Tianqiang
    Li, Ningxi
    Jiang, Yichun
    Yin, Huanli
    Wu, Min
    PHARMAZIE, 2020, 75 (04): : 124 - 130
  • [45] On the Biopharmaceutics Classification System Biowaiver of Ibuprofen
    Garcia-Arieta, Alfredo
    Gordon, John
    Potthast, Henrike
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 104 (08) : 2429 - 2432
  • [46] Biopharmaceutics Classification System: A Regulatory Approach
    Reddy, B. Basanta Kumar
    Karunakar, A.
    DISSOLUTION TECHNOLOGIES, 2011, 18 (01): : 31 - 37
  • [47] Effect of Common Excipients on the Oral Drug Absorption of Biopharmaceutics Classification System Class 3 Drugs Cimetidine and Acyclovir
    Vaithianathan, Soundarya
    Haidar, Sam H.
    Zhang, Xinyuan
    Jiang, Wenlei
    Avon, Christopher
    Dowling, Thomas C.
    Shao, Changxing
    Kane, Maureen
    Hoag, Stephen W.
    Flasar, Mark H.
    Ting, Tricia Y.
    Polli, James E.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 105 (02) : 996 - 1005
  • [48] BDDCS Predictions, Self-Correcting Aspects of BDDCS Assignments, BDDCS Assignment Corrections, and Classification for more than 175 Additional Drugs
    Hosey, Chelsea M.
    Chan, Rosa
    Benet, Leslie Z.
    AAPS JOURNAL, 2016, 18 (01): : 251 - 260
  • [49] Bioequivalence of Oral Products and the Biopharmaceutics Classification System: Science, Regulation, and Public Policy
    Amidon, K. S.
    Langguth, P.
    Lennernas, H.
    Yu, L.
    Amidon, G. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (03) : 467 - 470
  • [50] DRUG SOLUBILITY IN THE CONTEXT OF AN INHALATION-BASED BIOPHARMACEUTICS CLASSIFICATION SYSTEM (IBCS)
    Floroiu, Andreea
    Loretz, Brigitta
    Kraemer, Johannes
    Lehr, Claus-Michael
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2023, 36 (06) : A10 - A10